Increased RNA-induced silencing complex (RISC) activity contributes to hepatocellular carcinoma
about
MTDH-SND1 interaction is crucial for expansion and activity of tumor-initiating cells in diverse oncogene- and carcinogen-induced mammary tumorsMultifunction protein staphylococcal nuclease domain containing 1 (SND1) promotes tumor angiogenesis in human hepatocellular carcinoma through novel pathway that involves nuclear factor κB and miR-221AEG-1/MTDH/LYRIC in liver cancerAEG-1/MTDH/LYRIC: clinical significanceStaphylococcal nuclease domain containing-1 (SND1) promotes migration and invasion via angiotensin II type 1 receptor (AT1R) and TGFβ signalingSuppression of miR-184 in malignant gliomas upregulates SND1 and promotes tumor aggressivenessAstrocyte elevated gene-1 promotes hepatocarcinogenesis: novel insights from a mouse modelAEG-1/MTDH/LYRIC, the beginning: initial cloning, structure, expression profile, and regulation of expressionAstrocyte Elevated Gene-1 (AEG-1) Contributes to Non-thyroidal Illness Syndrome (NTIS) Associated with Hepatocellular Carcinoma (HCC).Paternal stress exposure alters sperm microRNA content and reprograms offspring HPA stress axis regulationMTDH promotes glioma invasion through regulating miR-130b-ceRNAs.The long noncoding RNA SPRIGHTLY acts as an intranuclear organizing hub for pre-mRNA moleculesProgress of cancer research on astrocyte elevated gene-1/Metadherin (Review).Transposon mutagenesis identifies genes driving hepatocellular carcinoma in a chronic hepatitis B mouse modelAEG-1 regulates retinoid X receptor and inhibits retinoid signaling.Genetic ablation of metadherin inhibits autochthonous prostate cancer progression and metastasisRole of the staphylococcal nuclease and tudor domain containing 1 in oncogenesis (review).siRNA induces gelsolin gene transcription activation in human esophageal cancer cell.Structural insights into the tumor-promoting function of the MTDH-SND1 complex.Astrocyte elevated gene-1 and c-Myc cooperate to promote hepatocarcinogenesis in mice.Tudor staphylococcal nuclease (Tudor-SN), a novel regulator facilitating G1/S phase transition, acting as a co-activator of E2F-1 in cell cycle regulation.The promoter of cell growth- and RNA protection-associated SND1 gene is activated by endoplasmic reticulum stress in human hepatoma cellsAstrocyte elevated gene 1: biological functions and molecular mechanism in cancer and beyond.Genetic Deficiency of Mtdh Gene in Mice Causes Male Infertility via Impaired Spermatogenesis and Alterations in the Expression of Small Non-coding RNAs.Cytoplasmic Metadherin (MTDH) provides survival advantage under conditions of stress by acting as RNA-binding protein.Illumina Sequencing Reveals Aberrant Expression of MicroRNAs and Their Variants in Whitefish (Coregonus lavaretus) Liver after Exposure to Microcystin-LR.Astrocyte elevated gene-1 regulates astrocyte responses to neural injury: implications for reactive astrogliosis and neurodegeneration.The role of AEG-1 in the development of liver cancer.The regulatory role of microRNA-1187 in TNF-α-mediated hepatocyte apoptosis in acute liver failure.Staphylococcal Nuclease and Tudor Domain Containing 1 (SND1 Protein) Promotes Hepatocarcinogenesis by Inhibiting Monoglyceride Lipase (MGLL).DYT-40, a novel synthetic 2-styryl-5-nitroimidazole derivative, blocks malignant glioblastoma growth and invasion by inhibiting AEG-1 and NF-κB signaling pathways.New insights on the role of epigenetic alterations in hepatocellular carcinoma.Astrocyte elevated gene-1 is associated with metastasis in head and neck squamous cell carcinoma through p65 phosphorylation and upregulation of MMP1AEG-1/MTDH/LYRIC: signaling pathways, downstream genes, interacting proteins, and regulation of tumor angiogenesis.miR-320a functions as a suppressor for gliomas by targeting SND1 and β-catenin, and predicts the prognosis of patients.Tudor domain-containing proteins of Drosophila melanogaster.Drug resistance mediated by AEG-1/MTDH/LYRIC.The role of AEG-1/MTDH/LYRIC in the pathogenesis of central nervous system diseaseAdvanced mass spectrometry-based multi-omics technologies for exploring the pathogenesis of hepatocellular carcinoma.Therapeutic microRNAs targeting the NF-kappa B signaling circuits of cancers.
P2860
Q24300043-1432D507-449B-4172-9E43-1B5D5A1FC32CQ24631381-3519AFEE-D982-4244-8D35-BAFB65796412Q26822570-91B8EB3F-29F8-4EA8-B78A-576BA6985B54Q27014932-118D370B-67A9-4B6D-BED5-5755720812D6Q28241756-40E6EF2A-A8DC-4578-AD30-5B250F80138AQ28247786-1EAFC05C-2FC9-453E-A1A8-E087CFA087D0Q28268632-27A9D38C-71C3-42DC-AEAC-0C59198C2D18Q28658809-3230B335-809A-4322-845E-954446F10288Q30299999-0F1678C6-BD1D-4F37-AADE-224659103BFBQ30446882-E9A7775C-B64D-49D5-885A-AD525C2375BDQ33566650-86DC470B-8EB6-4ECD-A2FC-86DEAD3F2394Q33633347-78C4B2C9-87BA-4592-9DF9-7C673085BDD4Q33844259-C8FF0471-355B-4C4A-A201-4A8B552970C5Q34038257-7BE79C55-5DA8-4BC4-87E5-675CDD342513Q34055706-367732D8-84FA-4564-8038-E94D859CEA27Q34205248-1DDF017E-F853-4B00-B851-8675A0F89C7CQ34775841-BEC85F9C-581A-4B00-8F35-FF8ABE5CB76EQ34983806-93BE1312-BFAB-40D5-BB0E-775520A905A0Q35022820-6AF41850-F43C-4140-9B0C-453B9BD5E1B9Q35024139-2609169E-A9DC-4677-8778-09352F730EBAQ35172690-AEE5A5D5-1855-43D2-9916-DA79B3F744F1Q35508316-FEACA083-D7E5-4E3E-A660-D5347169100BQ35565980-E3FD5F11-CE16-4364-9A3F-5BE7E9954F48Q35583031-4958C9B9-C5AA-4946-AA73-520DA06EE9B8Q35762980-A1044370-D35D-4DA1-94E1-E7AC35E79143Q36070928-0F5F8762-8C1B-48AA-B792-E53EED9D44FFQ36369806-F5393807-DAAE-469B-94C5-D06CAC4AE099Q36476816-FC278E3E-FA6E-49D2-984B-F642EDC775FEQ36613727-3B1C0B69-839C-47C5-85E0-0FE53273D3C8Q36898265-DECC7D45-6C27-4FE5-9E95-E5197B01B57BQ36960228-5D3E19B5-4C30-4BFA-8754-17B0CBB76494Q37031728-C41F4C68-15F1-4874-A865-4CB953A30934Q37376668-8C30699B-A335-4E9B-84D0-5E51F6B00F49Q37592555-41C9E982-FDF5-45EA-9293-A6613D5FB8C3Q37746117-909AF691-C5F5-4E09-B259-AF8561387AC9Q38112434-92A6552C-A0E0-447A-A3F0-2ED7BBD10A52Q38124429-72A01D95-8DC1-4486-B81A-EA6CD3D1F39DQ38124430-9D0AB783-83C3-4392-A6CD-BF62FDCA5C1FQ38217062-89F71937-5BB5-4264-9FAA-1E2349AE9437Q38249091-7B9D0E20-B15F-4771-8C5A-38AADD42D501
P2860
Increased RNA-induced silencing complex (RISC) activity contributes to hepatocellular carcinoma
description
2011 nî lūn-bûn
@nan
2011 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Increased RNA-induced silencin ...... es to hepatocellular carcinoma
@ast
Increased RNA-induced silencin ...... es to hepatocellular carcinoma
@en
Increased RNA-induced silencin ...... es to hepatocellular carcinoma
@nl
type
label
Increased RNA-induced silencin ...... es to hepatocellular carcinoma
@ast
Increased RNA-induced silencin ...... es to hepatocellular carcinoma
@en
Increased RNA-induced silencin ...... es to hepatocellular carcinoma
@nl
prefLabel
Increased RNA-induced silencin ...... es to hepatocellular carcinoma
@ast
Increased RNA-induced silencin ...... es to hepatocellular carcinoma
@en
Increased RNA-induced silencin ...... es to hepatocellular carcinoma
@nl
P2093
P2860
P3181
P356
P1433
P1476
Increased RNA-induced silencin ...... es to hepatocellular carcinoma
@en
P2093
Byoung Kwon Yoo
Devanand Sarkar
Lewis Pannell
Luni Emdad
Paul B Fisher
Prasanna K Santhekadur
Rachel Gredler
P2860
P304
P3181
P356
10.1002/HEP.24216
P407
P577
2011-05-01T00:00:00Z